Mark Cuban is an entrepreneur and philanthropist whose work has influenced access to medicines and healthcare affordability. He is the Founder of the Mark Cuban Cost Plus Drug Company (MCCPDC), launched to reduce drug prices through transparent, cost-based pricing, including a growing portfolio of oncology and supportive care medications. The company has partnered with health systems and payers to improve access to generic cancer drugs and reduce financial toxicity for patients. Cuban has also supported cancer research and innovation through philanthropic investments and public advocacy focused on healthcare system reform and drug pricing transparency.
The 100 Most Influential People in Oncology in 2025 recognizes the changemakers in cancer care who have helped shape current practice in oncology and continue to drive innovation and research towards better outcomes, advocacy, philanthropy, leadership and education. For the many deserving individuals not mentioned in this list, we will continue to acknowledge, honor and elevate your voices in our daily publications from across the world.
See the full list of The 100 Influential People in Oncology in 2025 and stay tuned for the results of special category nominations to be announced.
